Latest News
UEG introduces new Patient Representatives Advisory Board
19 October 2026 - United European Gastroenterology (UEG), an Austria-based nonprofit involved digestive health in Europe and beyond, on Sunday announced the launch of its new Patient Representatives Advisory Board (PRAB), that it says creates a dedic...
Vivacta Bio and Grit Bio's in vivo CAR-T therapy GT801 receives US FDA Orphan Drug Designation for autoimmune haemolytic anaemia
19 October 2026 - Vivacta Biotechnology (Shanghai) Co Ltd (Vivacta Bio), a China-based company spun out of the in vivo CAR-T platform of Beijing Grit Biotherapeutics Co Ltd (Grit Bio), announced on Saturday that the U.S. Food and Drug Administration ...
Viatris' RYZUMVI receives US FDA Approval to treat presbyopia
19 October 2026 - Pennsylvania-based global healthcare company Viatris Inc (Nasdaq: VTRS) announced on Friday that the US Food and Drug Administration (FDA) has approved RYZUMVI (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia...
Omeros receives negative EU opinion on narsoplimab after re-examination
16 October 2026 - Biotechnology company Omeros Corporation (Nasdaq:OMER) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) maintained its negative opinion on the marketing authorisatio...
Ionis' TRYNGOLZA recommended for EU approval in severe hypertriglyceridemia
16 October 2026 - Biotechnology company Ionis Pharmaceuticals Inc (Nasdaq:IONS) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of TRYNGOLZA (olezarsen) for ...